68 related articles for article (PubMed ID: 11733995)
1. Tumor cell growth inhibition and extracellular signal-regulated kinase (ERK) phosphorylation by novel K vitamins.
Osada S; Osada K; Carr BI
J Mol Biol; 2001 Dec; 314(4):765-72. PubMed ID: 11733995
[TBL] [Abstract][Full Text] [Related]
2. K vitamins, PTP antagonism, and cell growth arrest.
Carr BI; Wang Z; Kar S
J Cell Physiol; 2002 Dec; 193(3):263-74. PubMed ID: 12384979
[TBL] [Abstract][Full Text] [Related]
3. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin.
Wang Z; Wang M; Carr BI
J Cell Physiol; 2000 Jun; 183(3):338-46. PubMed ID: 10797308
[TBL] [Abstract][Full Text] [Related]
4. Critical role of extracellular signal-regulated kinase phosphorylation on menadione (vitamin K3) induced growth inhibition.
Osada S; Saji S; Osada K
Cancer; 2001 Mar; 91(6):1156-65. PubMed ID: 11267961
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
Wang Z; Ge L; Wang M; Carr BI
J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
[TBL] [Abstract][Full Text] [Related]
6. Involvement of Cdc25A phosphatase in Hep3B hepatoma cell growth inhibition induced by novel K vitamin analogs.
Wang Z; Southwick EC; Wang M; Kar S; Rosi KS; Wilcox CS; Lazo JS; Carr BI
Cancer Res; 2001 Oct; 61(19):7211-6. PubMed ID: 11585757
[TBL] [Abstract][Full Text] [Related]
7. Involvement of c-Myc in growth inhibition of Hep 3B human hepatoma cells by a vitamin K analog.
Ge L; Wang Z; Wang M; Kar S; Carr BI
J Hepatol; 2004 Nov; 41(5):823-9. PubMed ID: 15519656
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition and protein tyrosine phosphorylation in MCF 7 breast cancer cells by a novel K vitamin.
Kar S; Carr BI
J Cell Physiol; 2000 Dec; 185(3):386-93. PubMed ID: 11056008
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of novel vitamin K analog induced growth inhibition in human hepatoma cell line.
Osada S; Carr BI
J Hepatol; 2001 May; 34(5):676-82. PubMed ID: 11434613
[TBL] [Abstract][Full Text] [Related]
10. 2-Methyl-1,4-naphthoquinone, vitamin K(3), decreases gap-junctional intercellular communication via activation of the epidermal growth factor receptor/extracellular signal-regulated kinase cascade.
Klotz LO; Patak P; Ale-Agha N; Buchczyk DP; Abdelmohsen K; Gerber PA; von Montfort C; Sies H
Cancer Res; 2002 Sep; 62(17):4922-8. PubMed ID: 12208742
[TBL] [Abstract][Full Text] [Related]
11. Extracellular signal-regulated kinase phosphorylation due to menadione-induced arylation mediates growth inhibition of pancreas cancer cells.
Osada S; Sakashita F; Hosono Y; Nonaka K; Tokuyama Y; Tanaka H; Sasaki Y; Tomita H; Komori S; Matsui S; Takahashi T
Cancer Chemother Pharmacol; 2008 Jul; 62(2):315-20. PubMed ID: 17922126
[TBL] [Abstract][Full Text] [Related]
12. Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK.
Kar S; Wang M; Ham SW; Carr BI
Biochem Pharmacol; 2006 Nov; 72(10):1217-27. PubMed ID: 16930563
[TBL] [Abstract][Full Text] [Related]
13. Transient and sustained ERK phosphorylation and nuclear translocation in growth control.
Adachi T; Kar S; Wang M; Carr BI
J Cell Physiol; 2002 Aug; 192(2):151-9. PubMed ID: 12115721
[TBL] [Abstract][Full Text] [Related]
14. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
Guha S; Lunn JA; Santiskulvong C; Rozengurt E
Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
[TBL] [Abstract][Full Text] [Related]
15. Cdc25A and ERK interaction: EGFR-independent ERK activation by a protein phosphatase Cdc25A inhibitor, compound 5.
Wang Z; Zhang B; Wang M; Carr BI
J Cell Physiol; 2005 Aug; 204(2):437-44. PubMed ID: 15672448
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of rat liver regeneration after partial hepatectomy and induction of ERK phosphorylation by Cpd 5, a K vitamin-based anticancer compound.
Kar S; Wang M; Rosi KS; Wilcox CS; Carr BI
Carcinogenesis; 2004 Dec; 25(12):2345-51. PubMed ID: 15319298
[TBL] [Abstract][Full Text] [Related]
17. EGFR-independent activation of ERK1/2 mediates growth inhibition by a PTPase antagonizing K-vitamin analog.
Kar S; Adachi T; Carr BI
J Cell Physiol; 2002 Mar; 190(3):356-64. PubMed ID: 11857451
[TBL] [Abstract][Full Text] [Related]
18. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
[TBL] [Abstract][Full Text] [Related]
19. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK).
Aguirre-Ghiso JA; Estrada Y; Liu D; Ossowski L
Cancer Res; 2003 Apr; 63(7):1684-95. PubMed ID: 12670923
[TBL] [Abstract][Full Text] [Related]
20. Binding and inhibition of Cdc25 phosphatases by vitamin K analogues.
Kar S; Lefterov IM; Wang M; Lazo JS; Scott CN; Wilcox CS; Carr BI
Biochemistry; 2003 Sep; 42(35):10490-7. PubMed ID: 12950176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
